DKHH.JK PT Cipta Sarana Medika Tbk
- Market cap
- IDR 319B
- P/E
- -
- P/B
- -
- ROE
- 1.9%
- Dividend yield
- -
- Fundamental score
- 0.5/5
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2025.
Is DKHH.JK undervalued?
Graham numberThe Graham number of PT Cipta Sarana Medika Tbk cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
PT Cipta Sarana Medika Tbk fundamental analysis
3 of 22 checks passedROE 0/2
Low return on equity (1.9%), below 10%.
ROA 0/1
Return on assets (1.1%) is below the industry median (2.5%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Earnings growth cannot be compared with the industry.
Revenue Growth 0/2
Revenue did not grow over the past 3 years or is not reported.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 1/2
Moderate debt to equity (48.9%), up to 100%.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Debt Coverage 0/1
Operating cash flow does not cover 20% of total debt.
Interest Coverage 0/1
No interest expense reported.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book is negative or not available.
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
PT Cipta Sarana Medika Tbk stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About PT Cipta Sarana Medika Tbk
PT Cipta Sarana Medika Tbk, through its subsidiaries, owns and operates hospital in Indonesia. The company offers healthcare and physical treatment activities both for outpatient and inpatient care under private general, maternity, and specialized hospitals. It also provides medical services through internal medicine, pediatric, neurosurgery, obstetrics and gynecology, cardiology and vascular medicine, urology, pulmonology, orthopedics and traumatology, neurology, otorhinola…
Full company profilePT Cipta Sarana Medika Tbk financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
PT Cipta Sarana Medika Tbk annual financial statements
| Item | 2023 | 2025 Anlz |
|---|---|---|
| Income Statement | ||
| Revenue | 134B | 198B |
| Gross Profit | 44.6B | 47.6B |
| Operating Income | 9.67B | 11.7B |
| Net Income | 508M | 3.82B |
| EPS | 0.20 | 1.50 |
| Balance Sheet | ||
| Total Assets | 301B | 336B |
| Total Liabilities | 172B | 135B |
| Shareholders' Equity | 129B | 201B |
| Cash & Short-term Investments | 2.46B | 25.3B |
| Cash Flow | ||
| Operating Cash Flow | 19.7B | 6.22B |
| Capital Expenditure | 36.1B | 114B |
| Ratios | ||
| ROE | 0.4% | 1.9% |
| ROA | 0.2% | 1.1% |
| Net Profit Margin | 0.4% | 1.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
PT Cipta Sarana Medika Tbk dividends
PT Cipta Sarana Medika Tbk has not paid dividends in the last 1 fiscal years.
Who owns PT Cipta Sarana Medika Tbk
- Insiders 79.21%
- Institutions 0.00%
- Public & others 20.79%
- Shares outstanding 2.55B
- Free float 530M
PT Cipta Sarana Medika Tbk company profile
- Company name
- PT Cipta Sarana Medika Tbk
- Ticker
- DKHH.JK
- Exchange
- Jakarta Exchange
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Employees
- 578
- Fiscal year end
- December
- Address
- Jl Siliwangi No. 139, Cibadak, Sukabumi, Indonesia, 43351
- Phone
- 62 21 4586 9050
- Website
- dkhhospitals.com
About PT Cipta Sarana Medika Tbk
PT Cipta Sarana Medika Tbk, through its subsidiaries, owns and operates hospital in Indonesia. The company offers healthcare and physical treatment activities both for outpatient and inpatient care under private general, maternity, and specialized hospitals. It also provides medical services through internal medicine, pediatric, neurosurgery, obstetrics and gynecology, cardiology and vascular medicine, urology, pulmonology, orthopedics and traumatology, neurology, otorhinolaryngology, ophthalmology, medical rehabilitation, general dentistry, general practitioner, physiotherapy, oral and general surgery, as well as dermatology, venereology, and aesthetics clinics. In addition, the company offers healthpedia. The company was founded in 2014 and is based in Sukabumi, Indonesia. PT Cipta Sarana Medika Tbk is a subsidiary of PT Siliwangi Djajakusumah Hospitals.
PT Cipta Sarana Medika Tbk management
3- Mr. Satria Muhammad Wilis M.Sc.President Director · born 1998
- Dr. Octen SuhadiDirector of Finance & Director · born 1980
- Mr. Heri AkhyarCorporate Secretary · born 1969